September 20, 2021

Endometrial Sampling Has a Role in Detecting Leiomyosarcoma

Study identifies factors that improve preoperative detection and procedures

uterine leiomyosarcoma

A recent study of the effectiveness of endometrial sampling in detecting leiomyosarcoma (LMS), an aggressive uterine cancer with a poor prognosis, indicates that when sampling is done in conjunction with hysteroscopy before hysterectomy, there is a threefold increase in pre-operative diagnosis.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Rosanne M. Kho, MD, of Cleveland Clinic’s Women’s Health Institute, was lead author on the research published in the Journal of Minimally Invasive Gynecology.

Rethinking the utility of endometrial sampling

Symptoms of leiomyosarcoma often mimic uterine leiomyomas, which can include abnormal bleeding, pelvic pain and infertility. While LMS is rare, occurring in only 13 out of 10,000 surgeries for presumed leiomyomas, the prognosis for LMS patients is poor. The five-year survival rate for disease diagnosed at stage I is 55.4%; at stage IV it is 13.1%.

Pre-surgical diagnosis is notably difficult. Postmenopausal and Black women are at higher risk, as are those with a history of pelvic radiation, extended use of tamoxifen, and those who present with a single, rapidly increasing tumor with atypical features. No diagnostic test exists to reliably differentiate LMS tumors from a benign fibroid.

“We are continually trying to find ways to catch these patients before we go in with surgery,” Dr. Kho says. “First of all, in many situations of leiomyosarcoma, surgery should not be the first approach. Secondly, if surgery is to be performed, you need to be ready with the right team. It has to be in the hands of the oncologists.”

The researchers examined linked data from the New York Statewide Planning and Research Cooperative System and the New York State Cancer Registry from 2003 to 2015. The study subjects were women with uterine leiomyosarcoma who had undergone endometrial sampling within 90 days before a hysterectomy. Among 79 cases that met the sampling criteria, 46 received a preoperative diagnosis of LMS and 33 had been diagnosed post-operatively.

Advertisement

Leiomyosarcoma was picked up by endometrial sampling about 58% of the time.

“Historically, it was thought that these cancers were contained only within the myometrium, and that therefore an endometrial sampling would be not very helpful, because you’re not actually sampling the tumor itself,” says Dr. Kho. “To find that 58% of the time the result is positive suggests that it’s worthwhile.”

In addition, the study found that the detection rate tripled for cases in which hysteroscopy was used during sampling procedures — pipelle biopsy or dilation and curettage.

“The assumption is that when you use hysteroscopy, you can better direct where to sample,” Dr. Kho says. “Hysteroscopy at the time of sampling should be the gold standard. It has been declared as a gold standard for over 10 years, yet it still is not routinely done. There’s a role for preoperative sampling, and if preoperative sampling is to be done, consider using hysteroscopy and not perform a blind sampling alone.”

The researchers also found that in some women whose diagnosis of LMS was not detected before surgery, the chosen procedure was supracervical hysterectomy. “We know that you don’t do that in cancer surgery,” Dr. Kho says.

Advertisement

In general, she adds, the advantages of supracervical hysterectomy have been shown to be minimal.

“There is strong evidence from the Cochrane Review that it really does not confer any advantage other than the fact that you do not subject the patient to a vaginal cuff dehiscence,” says Dr. Kho. “There are no benefits in terms of bladder, bowel or sexual function in leaving the cervix behind. It used to be thought that if you leave the cervix behind, there’s better sexual function or there is less risk of a prolapse or fewer complications, but that did not bear out as true.”

The endometrial sampling study did not find that the prognosis or the survival rate was worse in women whose diagnosis were missed. Dr. Kho attributes that to possibly the limited sample size in the retrospective research. A prospective study that gathers data from medical centers across the country will be needed, she says.

Related Articles

Pelvic prolapse
June 30, 2023
Native-Tissue Pelvic Prolapse Surgery Improves Sexual Function

Study indicates patients can have confidence about potential outcomes

adenomyoma
January 16, 2023
Diagnosis and Treatment of Refractory Pelvic Pain

Laparoscopic surgery provides relief for teenage patient with adenomyoma and endometriosis

uterteral endometriosis
January 9, 2023
Three Specialists Perform Robotic Surgery to Remove Endometrial Nodule

A large nodule had strangulated the patient’s ureter and invaded the vagina, bladder and rectum

Diaphragmatic endometriosis
December 15, 2022
Robotic Surgery for Pelvic and Diaphragmatic Endometriosis

Case study: Concomitant robot-assisted surgery without repositioning the patient

ovarian cancer
September 1, 2022
Study Supports Salpingo-Oophorectomy for Management of Incidental Endometrioma in Premenopausal Women

Analysis compares ovary removal to surveillance in asymptomatic patients

mullerian anomaly
March 3, 2022
New Centralized Care for Patients with Mullerian Anomalies

Cleveland Clinic delivers team approach to diagnosis and treatment of rare condition

Diaphragmatic endometriosis
January 7, 2022
Considerations for Diaphragmatic Endometriosis Surgery

Tips and techniques to help optimize resection and ablation of lesions in the diaphragm

Laparoscopic image revealing a cesarean section scar ectopic pregnancy at 9+5 weeks gestation.
April 13, 2021
Laparoscopic Resection of Cesarean Scar Ectopic Pregnancy

A case study of this rare presentation

Ad